Key Highlights

● RLX Technology fell on August 14, 2026 after reporting second-quarter results that beat on Revenue growth.

● The company missed Wall Street's profit expectations, the primary driver of the negative reaction.

● Shares closed down roughly 3% on the day at $1.94, reflecting the mixed results.

● RLX Technology, the Chinese e-vapor company behind the Relx brand, continues pursuing a European market push.

RLX Technology Inc. (NYSE: RLX), the Chinese e-vapor company behind the Relx brand, fell on August 14, 2026, after reporting second-quarter results that beat on revenue growth but missed Wall Street's profit expectations. Shares closed down roughly 3% on the day at $1.94, then gapped further lower the following session, based on multiple market data providers. The move came even as the company posted its 14th straight quarter of year-over-year revenue growth and a sharp jump in gross margin, underscoring how sensitive the stock remains to the pace, not just the direction, of its Earnings recovery. RLX continues to sit on a large net cash balance and has an active buyback program, but investors appeared more focused on decelerating profitability than on the balance sheet.

Latest Development

RLX reported unaudited second-quarter 2026 results on August 14. Net revenue rose 14.8% year-over-year to RMB1,010.5 million (US$148.9 million), with international markets, Europe, Southeast Asia, the Middle East and other regions outside mainland China, accounting for roughly 68.5% of total revenue. Gross Margin expanded to 35.4% from 27.5% a year earlier, and Gross Profit climbed 47.8% year-over-year to RMB357.8 million.

Despite the margin improvement, non-GAAP Net Income fell to RMB238.8 million from RMB291.2 million a year earlier, and per-share results came in below analyst consensus, according to earnings-tracking services including Investing.com and MarketBeat, which cited a meaningful EPS and revenue shortfall versus Street estimates. GAAP net income was RMB222.0 million (US$32.7 million), up a modest 1.6% year-over-year. Management attributed part of the sequential moderation to a one-time benefit tied to a change in export-related regulation that had lifted first-quarter results but did not repeat in the second quarter.

Separately, RLX disclosed a July 2026 Acquisition of a 51% Equity stake in a Western European smoke-free products distributor, which management said serves more than 30,000 retail endpoints and over 20,000 independent merchants through a B2B platform; consolidation of that Business begins in the third quarter.

What the Numbers Show

The quarter's headline tension was growth-with-a-profit-miss. Revenue grew nearly 15% and gross margin expanded by roughly 790 basis points, driven by a richer international sales mix and contributions from a prior acquisition completed in May 2025. Yet selling expenses rose sharply, to RMB123.7 million from RMB84.6 million a year earlier, which management linked to acquisition-related costs, pressuring the Bottom Line relative to expectations. Operating Cash Flow was negative in the quarter, with RMB63.2 million used rather than generated.

RLX's Balance Sheet remains a standout feature: total cash, cash equivalents and investments stood at RMB13,883.4 million (US$2,046.2 million) as of June 30, 2026, though that was down from RMB14,529.7 million at the end of the first quarter, a roughly RMB646 million sequential decline. Against a market Capitalization in the $2–3 billion range following the post-earnings decline, the net cash position remains a substantial portion of the company's enterprise value, a dynamic that has persisted for several years and continues to shape bull-case arguments.

Why Investors Are Paying Attention

RLX's story has increasingly become one of geographic transformation. International sales now make up more than two-thirds of revenue, up from a business once almost entirely dependent on China, where tightened tobacco-style regulation, licensing requirements and flavor restrictions have constrained domestic growth since 2022. Management said on the Earnings Call that mainland China sales are expected to be "broadly flat year-over-year" given conservative regulatory approval timelines, reinforcing that international expansion, rather than the home market, is now the primary growth engine investors are underwriting.

The company also carries an active capital-return program: a $500 million share repurchase authorization that RLX extended through 2027, with up to roughly $170 million remaining as of the most recent disclosure at the end of 2025. RLX has also paid periodic dividends, including a materially larger payout with a January 2026 ex-dividend date compared with smaller distributions in prior years. Neither a new Dividend nor incremental buyback activity was announced alongside the Q2 print.

Bull Case

Bulls point to the combination of double-digit revenue growth, expanding gross margins, and a fortress balance sheet trading at a market cap not far above net cash, a setup some analysts argue implies the core operating business is being assigned little value. The European distributor acquisition gives RLX direct retail and merchant reach in a market management says it intends to grow "organically" rather than restructure, potentially compounding international share gains. Management has also framed tightening global vaping regulation, including proposed UK restrictions on packaging and retail display, as a net positive over time, arguing it eliminates non-compliant, illicit competitors and raises barriers for smaller rivals, which could favor a scaled, compliance-focused player like RLX.

Bear Case

Bears note that non-GAAP net income actually declined year-over-year even as revenue grew, and that the quarter missed consensus estimates on both revenue and Earnings Per Share by a wide margin according to multiple earnings trackers, a sign that international expansion may be diluting profitability, since distribution-heavy acquisitions like the European deal carry structurally lower margins than RLX's historical China business. Operating cash flow was negative in the quarter. China Regulatory Risk has not disappeared; approval timelines for new products remain conservative, and illegal, unlicensed vaping competition in China continues to be cited as a margin risk. The stock's five-year decline of nearly 50% reflects a long history of regulatory shocks reshaping the Investment case, and no single announcement in the current news cycle can be verified as the sole cause of the latest selloff beyond the earnings miss itself.

What Could Move the Stock Next?

Key catalysts include third-quarter results, which will be the first to consolidate the new European distributor and test management's claim that absolute operating profit, even if margin percentage compresses, can keep expanding. Additional buyback usage against the remaining ~$170 million authorization, any new dividend declaration, updates on Chinese regulatory approvals for new product categories, and developments in UK, EU or U.S. vaping regulation (including packaging and flavor rules) are all plausible near-term stock movers.

Revenue Strength, Profit Disappointment

RLX Technology's second quarter captured the central tension in its current story: robust top-line growth and improving gross margins on one hand, and a profit shortfall relative to expectations on the other, driven partly by acquisition-related costs tied to its international push. The company's large net cash position and active buyback authorization provide a financial cushion, but the market's reaction suggests investors are weighing execution risk in the European expansion and the durability of margins against the balance-sheet safety net. With China sales expected to stay roughly flat and global regulatory frameworks still evolving, RLX's near-term trajectory will likely hinge on how cleanly it integrates its new European distribution business and whether profitability metrics can catch up to revenue growth in coming quarters.